Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis-Reference-Cited by-同舟云学术

Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis

Published:2004-03-23 Issue:5 Volume:43 Page:640-647
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Strand V.,Cohen S.,Crawford B.,Smolen J. S.,Scott D. L.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/43/5/640/14117482/keh140.pdf

Reference55 articles.

1. Felson DT, Anderson JJ, Boers M et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum1993;36:729–40.

2. Bombardier C. The optimal use of cyclosporine A in rheumatoid arthritis: efficacy and outcome measures including quality of life. Br J Rheumatol1993;32(Suppl. 1):47–50.

3. Bombardier C, Buchbinder R, Tugwell P. Efficacy of cyclosporine A in rheumatoid arthritis: long term followup data and the effect on quality of life. Scand J Rheumatol1992;21:29–33.

4. Buchbinder R, Bombardier C, Yeung M, Tugwell P. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures’ responsiveness to treatment in a randomized clinical trial. Arthritis Rheum1995; 38:1568–80.

5. Tuttleman M, Pillemer SR, Tilley BC et al. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. J Rheumatol1997;24:1910–5.

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physician estimate of inflammation vs global assessment in explaining variations in swollen joint counts in rheumatoid arthritis patients;Rheumatology Advances in Practice;2024-01-01

2. Performance of the Rheumatoid Arthritis Disease Activity Index in the Assessment of Disease Activity in Rheumatoid Arthritis—Findings From the REAL Study;JCR: Journal of Clinical Rheumatology;2022-03-22

3. A Self-Report Multidimensional Health Assessment Questionnaire (MDHAQ) for Face-To-Face or Telemedicine Encounters to Assess Clinical Severity (RAPID3) and Screen for Fibromyalgia (FAST) and Depression (DEP);Current Treatment Options in Rheumatology;2021-07-28

4. Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study;Advances in Therapy;2021-01-11

Impact of Secukinumab on Patient-Reported Outcomes in the Treatment of Ankylosing Spondylitis: Current Perspectives

;Open Access Rheumatology: Research and Reviews;2020-11